Activation of Matrix Metalloproteinases Precedes Left Ventricular Remodeling in Hypertensive Heart Failure Rats
- 4 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (17) , 2143-2149
- https://doi.org/10.1161/01.cir.0000125741.88712.77
Abstract
Background— Matrix metalloproteinases (MMPs) are activated in dilated failing hearts, and angiotensin-converting enzyme (ACE) inhibition prevents left ventricular (LV) dilatation. However, it remains unclear whether activation of MMPs precedes or is secondary to LV remodeling, and an effect of ACE inhibition on MMPs is unknown. Methods and Results— Dahl salt-sensitive rats fed a high-salt diet from 8 weeks served as the hypertensive heart failure (HF) model. LV echo, histological study, measurement of mRNA levels, and gelatin zymography were performed before (at 23 weeks) and after (at 26 weeks) the development of LV dilatation and pulmonary edema. The same procedures were conducted in the HF model rats treated with a subdepressor dose of ACE inhibitor (enalapril 5 mg · kg−1 · d−1) from 9 weeks. Rats fed on normal chow served as age-matched controls. In the untreated HF model rats, gene expression of MMP-2 and MMP-9 and tissue gelatinase activity were elevated at 23 weeks without LV dilatation. LV dilatat...Keywords
This publication has 17 references indexed in Scilit:
- Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMPHeart, 2002
- Effects of Matrix Metalloproteinase Inhibition on Ventricular Remodeling Due to Volume OverloadCirculation, 2002
- Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive ratsJournal of the American College of Cardiology, 2002
- Effect of Ramipril and Furosemide Treatment on Interstitial Remodeling in Post-Infarction Heart Failure Rat HeartsJournal of Molecular and Cellular Cardiology, 2002
- Activation of matrix metalloproteinase dilates and decreases cardiac tensile strengthInternational Journal of Cardiology, 2001
- MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibitionCardiovascular Research, 2000
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJournal of the American College of Cardiology, 2000
- Development of different phenotypes of hypertensive heart failureJournal Of Hypertension, 2000
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- Role of Angiotensin in Angiogenesis and Cardiac Fibrosis in Heart FailurePublished by Springer Nature ,1998